Brittany Bychkovsky

2.1k total citations
37 papers, 286 citations indexed

About

Brittany Bychkovsky is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Brittany Bychkovsky has authored 37 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 17 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Brittany Bychkovsky's work include BRCA gene mutations in cancer (19 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Genomics and Diagnostics (10 papers). Brittany Bychkovsky is often cited by papers focused on BRCA gene mutations in cancer (19 papers), Breast Cancer Treatment Studies (10 papers) and Cancer Genomics and Diagnostics (10 papers). Brittany Bychkovsky collaborates with scholars based in United States, Brazil and Türkiye. Brittany Bychkovsky's co-authors include Nancy U. Lin, Judy E. Garber, Rochelle Scheib, Gilberto Lopes, Huma Q. Rana, Marcy E. Richardson, Carolyn Horton, Amal Yussuf, Holly LaDuca and Deborah L. McGuinness and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Brittany Bychkovsky

29 papers receiving 282 citations

Peers

Countries citing papers authored by Brittany Bychkovsky

Since Specialization

Citations

This map shows the geographic impact of Brittany Bychkovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brittany Bychkovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brittany Bychkovsky more than expected).

Fields of papers citing papers by Brittany Bychkovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brittany Bychkovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brittany Bychkovsky. The network helps show where Brittany Bychkovsky may publish in the future.

Co-authorship network of co-authors of Brittany Bychkovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Brittany Bychkovsky. A scholar is included among the top collaborators of Brittany Bychkovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brittany Bychkovsky. Brittany Bychkovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism 2025 ·Clinical Cancer Research ·A. Rodríguez, Linda M. Polfus, Brittany Bychkovsky, (unknown), Aleix Prat, Bárbara Adamo, Judy E. Garber, Carolyn Horton, Huma Q. Rana	0
2	CHEK2-related breast cancer: real-world challenges 2025 ·Familial Cancer ·(unknown), Brittany Bychkovsky, (unknown), Romualdo Barroso‐Sousa, Renata Lazari Sandoval	1
3	Impact of the American Society of Breast Surgeons’ Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates 2025 ·Annals of Surgical Oncology ·Anna Weiss, Mário Antonello Rosito, Danielle Braun, (unknown), Monica McGrath, (unknown), Alison Laws, Lorraine Warren, Stefania Morganti, Filipa Lynce, Brittany Bychkovsky, (unknown), Dillon Davis, Jill E. Stopfer, Judy E. Garber, Tari A. King	0
4	Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes 2025 ·JAMA Network Open ·Brittany Bychkovsky, Nihat Buğra Ağaoğlu, Carolyn Horton, Linda M. Polfus, Marcy E. Richardson, Colin C. Young, Rochelle Scheib, Judy E. Garber, (unknown)	1
5	Ductal Carcinoma In Situ 2024 ·Hematology/Oncology Clinics of North America ·Brittany Bychkovsky, (unknown), Laura Warren, Pietro De Placido, Heather A. Parsons	0
6	Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye 2024 ·Cancers ·Özkan Özdemir, Brittany Bychkovsky, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Naci Çine, (unknown), Huma Q. Rana, Özden Hatırnaz Ng, Nihat Buğra Ağaoğlu	0
7	TP53-associated early breast cancer: new observations from a large cohort 2024 ·JNCI Journal of the National Cancer Institute ·Renata Lazari Sandoval, Michele Bottosso, Tianyu Li, (unknown), Brittany Bychkovsky, Benjamin Verret, Alessandra Gennari, (unknown), Maria Isabel Achatz, Olivier Caron, (unknown), Catherine Noguès, (unknown), Cristina Fortuño, Amanda B. Spurdle, Nabihah Tayob, Fabrice André, Judy E. Garber	6
8	Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes 2024 ·SHILAP Revista de lepidopterología ·Nihat Buğra Ağaoğlu, Brittany Bychkovsky, Carolyn Horton, Min‐Tzu Lo, Linda M. Polfus, (unknown), (unknown), Colin C. Young, Marcy E. Richardson, Rochelle Scheib, Judy E. Garber, (unknown)	5
9	Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception 2023 ·Breast Cancer Research and Treatment ·Brittany Bychkovsky, Min‐Tzu Lo, Amal Yussuf, Carolyn Horton, (unknown), Holly LaDuca, Judy E. Garber, Rochelle Scheib, Huma Q. Rana	0
10	Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study 2023 ·BMC Primary Care ·(unknown), Brittany Bychkovsky, Erica T. Warner, Tari A. King, Rachel A. Freedman, Elizabeth A. Mittendorf, (unknown), Anna Revette, Danielle M. Crookes, (unknown), Lydia E. Pace	3
11	Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps 2023 ·JCO Precision Oncology ·(unknown), Filipa Lynce, Colleen M. Feltmate, Michelle Davis, Michael G. Muto, Panagiotis A. Konstantinopoulos, Elizabeth H. Stover, Allison W. Kurian, Sarah J. Hill, Ann H. Partridge, Sara M. Tolaney, Judy E. Garber, Brittany Bychkovsky	6
12	Abstract P5-14-06: Tumor Genomic Landscape in Older Women with Metastatic Breast Cancer (MBC) 2023 ·Cancer Research ·Hersh Gupta, Rachel A. Freedman, Melissa E. Hughes, Yvonne Y. Li, Gregory J. Kirkner, Janet Files, (unknown), Ana C. Garrido-Castro, (unknown), Romualdo Barroso‐Sousa, Brittany Bychkovsky, Sara M. Tolaney, Laura E. MacConaill, Neal Lindeman, Bruce Johnson, Matthew Meyerson, Eric P. Winer, Deborah Dillon, Andrew D. Cherniack, Nancy U. Lin	0
13	Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies 2023 ·The Oncologist ·Stefania Morganti, Brittany Bychkovsky, Philip D. Poorvu, Ana C. Garrido-Castro, Anna Weiss, Caroline Block, Ann H. Partridge, Giuseppe Curigliano, Nadine Tung, Nancy U. Lin, Judy E. Garber, Sara M. Tolaney, Filipa Lynce	5
14	Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen 2022 ·Breast Cancer Research and Treatment ·Brittany Bychkovsky, Alison Laws, (unknown), (unknown), (unknown), Lydia E. Pace, Rochelle Scheib, Judy E. Garber, Tari A. King	17
15	Call for action: expanding global access to hereditary cancer genetic testing 2022 ·The Lancet Oncology ·Brittany Bychkovsky, Huma Q. Rana, Foluso O. Ademuyiwa, Jennifer K. Plichta, Karen S. Anderson, Angélica Nogueira‐Rodrigues, Cesar A. Santa‐Maria, Lan Coffman, Carol Marquez, Arunangshu Das, A.G. Taghian, (unknown), Renata Lazari Sandoval, Ben Ho Park, Don S. Dizon	10
16	Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis 2022 ·Annals of Surgical Oncology ·Alison Laws, (unknown), (unknown), (unknown), Olga Kantor, Christina A. Minami, Brittany Bychkovsky, Lydia E. Pace, Rochelle Scheib, Judy E. Garber, Tari A. King	7
17	Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2 2022 ·JAMA Oncology ·Brittany Bychkovsky, Nihat Buğra Ağaoğlu, Carolyn Horton, Jing Zhou, Amal Yussuf, (unknown), Marcy E. Richardson, Colin C. Young, Holly LaDuca, Deborah L. McGuinness, Rochelle Scheib, Judy E. Garber, Huma Q. Rana	48
18	Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics 2021 ·Cancer ·Brittany Bychkovsky, Min‐Tzu Lo, Amal Yussuf, Carolyn Horton, Marcy E. Richardson, Holly LaDuca, Judy E. Garber, Huma Q. Rana	13
19	Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis 2018 ·Frontiers in Oncology ·Márcio Debiasi, Carísi Anne Polanczyk, Patrícia Klarmann Ziegelmann, Carlos H. Barrios, Hongyuan Cao, James J. Dignam, Paul E. Goss, Brittany Bychkovsky, Dianne M. Finkelstein, Rodrigo Santa Cruz Guindalini, (unknown), (unknown), Tomás Reinert, Evandro de Azambuja, Olufunmilayo Olopade	24
20	Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often? 2016 ·The Breast ·Brittany Bychkovsky, Nancy U. Lin	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact